Losing weight can be an important factor in managing, and in some cases even eliminating, a range of ongoing health problems.

Guardant Health has delivered exceptional growth, with revenue up 48% YoY and its Shield screening segment surging 633% YoY.

The Articulate Pro study evaluated real-world use of an artificial intelligence (AI) assisted prostate biopsy reporting system at 3 UK centers.

Enhancers are pieces of DNA that act like switches, regulating when genes are turned on and off and how strongly they are activated.

According to a study performed by Texas Health, 72% of men stated they would rather do household chores, such as cleaning the ...

(NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review a supplemental New Drug Application (sNDA) for TALZENNA ® (talazoparib), an oral poly ...

As Black communities continue to face persistent disparities in cancer outcomes—from breast cancer in women to prostate ...

Eikon Therapeutics trades at a small discount to cash but lacks near-term catalysts and robust clinical data. Click here to ...

A noninvasive DNA blood test can identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are most ...

Hundreds of new medicines remain stuck without pricing approval, leaving patients waiting while companies see investments frozen ...

New data from the Phase 1b/2 trial of NOUS-209 in Lynch Syndrome (LS) carriers have been accepted for an oral presentation at the European ...

CONMED Corporation (NYSE: CNMD) today announced its participation in the Society of Robotic Surgery (SRS) 2026 Annual Meeting, which is being held July 23-26, 2026 in Fort Lauderdale, FL. During the ...